The UK government has proposed changes to the definition of gene therapies and other genetic medicines, aiming to give ...
Sanofi is already a big player in Gaucher disease, selling the ERT Cerezyme (imiglucerase) for all three types, as well as ...
Diabetes drug development has changed more in the last 10 years than in the previous three decades combined. Indeed, today, ...
MSD has called a halt to three trials of BTK inhibitor nemtabrutinib – added to its pipeline through its $2.7 billion ...
Introducing Falcon MLR, Veeva's AI-powered review platform, Hyland described a future in which AI acts less like a piece of ...
Donald Trump nominated Overton – a White House aide, physician, and vocal opponent of abortion – in the summer. The following ...
The UK government has said it will end the NHS's controversial contract with US tech firm Palantir, but not until 2029 – two ...
Novo has published the results of a clinical trial of its Wegovy injection in children aged six to 12 with obesity, showing ...
Real-World Evidence for the Impact of Company-Led Medical Education – Medscape Medical Affairs explores the question of ...
Helus Pharma has revealed data from a phase 3 trial of HLP003 that showed evidence of efficacy in major depressive disorder ...
AstraZeneca's rare disease unit Alexion has won regulatory approval in the US and EU for Klygefa as a generalised myasthenia ...
Access and clarity should not be treated as separate problems. When organisations treat clarity as part of access, they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results